GlassScriptPhysician profile
Imtiaz Ismail
NPI 1114369170
$13,606.56
in general payments reported to CMS, 2019-2025
26 companies · $3,016 in 2025
The $3,016 reported for 2025 was more than what 75% of Interventional Cardiology providers received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $557 · 2020: $520 · 2021: $3,034 · 2022: $1,057 · 2023: $2,402 · 2024: $3,020 · 2025: $3,016.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $4,400 · Food and Beverage: $3,969 · Education: $68.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $4,399.69 |
| Food and Beverage | $3,968.90 |
| Education | $68.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $4,714.71 | 2021-2025 | Optis, Perclose Prostyle, Aveir |
| Medtronic, INC. | $2,134.36 | 2021-2025 | Micra, Onyx Frontier, Corevalve Evolut R |
| Edwards Lifesciences Corporation | $1,623.25 | 2021-2022 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $1,068.61 | 2019-2025 | Lifevest |
| Novartis Pharmaceuticals Corporation | $583.90 | 2019-2024 | |
| Shockwave Medical, INC | $552.21 | 2022-2025 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter, Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| W. L. Gore & Associates, INC. | $448.83 | 2023-2025 | Gore Viabahn Vbx Balloon Expandable Endo, Gore Viabahn Endoprosthesis |
| Cardiovascular Systems INC. | $442.65 | 2020-2021 | |
| Astrazeneca Pharmaceuticals LP | $315.14 | 2019-2023 | Brilinta, Farxiga |
| Actelion Pharmaceuticals US, INC. | $272.76 | 2021-2022 | |
| Inari Medical, INC. | $235.55 | 2021-2025 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Janssen Pharmaceuticals, INC | $207.24 | 2019-2023 | Xarelto |
| Abiomed | $204.94 | 2021-2024 | Impella |
| Amgen INC. | $165.79 | 2019-2024 | Repatha |
| Boston Scientific Corporation | $150.96 | 2021-2025 | Rotapro |
Show all 26 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Scpharmaceuticals INC. | $96.98 | 2024 | |
| Chiesi USA, INC. | $96.16 | 2020-2024 | Kengreal |
| Medtronic Vascular, INC. | $71.36 | 2020 | |
| E.R. Squibb & Sons, L.L.C. | $44.77 | 2019-2022 | |
| Terumo Medical Corporation | $42.02 | 2021 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $31.14 | 2021-2023 | Jardiance |
| Pfizer INC. | $28.40 | 2019 | |
| Stryker Corporation | $27.73 | 2025 | Flowtriever |
| Astellas Pharma US INC | $22.75 | 2019 | |
| Alnylam Pharmaceuticals INC. | $14.35 | 2022 | |
| Zoll Circulation INC | $10.00 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Imtiaz Ismail listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.